Emerging role of microbiota in immunomodulation and cancer immunotherapy.

Singh, Raghwendra Pratap; Bashir, Hilal; Kumar, Rashmi

Singh, Raghwendra Pratap; Bashir, Hilal; Kumar, Rashmi.

Affiliation

Singh RP; CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Bashir H; CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
Kumar R; CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: rashmi@imtech.res.in.

Semin Cancer Biol ; 70: 37-52, 2021 05.

Article in En | MEDLINE | ID: mdl-32580024

Subject(s)

Antineoplastic Agents/administration & dosage; Gastrointestinal Microbiome; Immunomodulation; Immunotherapy/methods; Neoplasms/drug therapy; Neoplasms/immunology; Prebiotics/administration & dosage; Animals; Humans; Neoplasms/microbiology

Key words

Cancer; FMT; Immunotherapy; Microbiome; Microbiota; Probiotics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prebiotics / Immunomodulation / Gastrointestinal Microbiome / Immunotherapy / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Semin Cancer Biol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google